Lymphoplasmacytic lymphoma
Lymphoplasmacytic lymphoma
Updated: 09/11/2024
© Jun Wang, MD, PhD
General features
- B cell disorder with features of both low grade lymphoma and myeloma
- Older patients
- Frequently involving bone marrow, lymph node, spleen, liver
- Rarely lytic bone lesion, amyloidosis, renal impairment
- Autoimmune hemolysis may occur
- May transform into Diffuse large B cell lymphoma
Clinical presentations
- Bone marrow abnormality: Anemia, thrombocytopenia, neutropenia
- Non specific: Lymphoadenopathy, hepatosplenomegaly
- Hyperviscosity syndrome
- May be asymptomatic
Key pathogenesis
- MYD88 mutation resulted in abnormal function of Toll-like receptor and Il-1 receptor signaling pathway
- Hyperviscosity results in abnormal platelet function
Key Laboratory findings
- Waldenstrom macroglobulinemia
- Serum IgM monoclonal gammopathy, M spike
- Monoclonal Ig light chains (Bence-Jones protein) in urine
- May have anemia and thrombocytopenia
- Prolonged thrombin time, probably due to inhibition of fibrin polymerization by IgM paraprotein
Key morphological features
- Small lymphocyte
- Abnormal plasma cells similar to plasmacytoma
Markers
- Positive: CD19, CD20, CD138, light chain restriction
Genetic abnormalities
- MYD88
Negative prognosis indicator
- Older age
- Anemia
- Albumin < 4 g/dl
- Elevated beta-2-microglobulin
Back to contents
Comments
Post a Comment